Regulatory Vet Continuing Education Organizers Honored: Bloodhorse 4/10/19

ARCI Press Release: On the closing day of its 2019 Racing Integrity and Animal Welfare Conference, held last week in Arcadia, Calif., the Association of Racing Commissioners International honored organizers of the annual Regulatory Veterinarian Continuing Education conference. The special President's Award, recognizing exemplary service and contribution to racing integrity, was presented to Dr. Dionne

Best Practices, Best Outcomes Discussed on Day 2 of Regulatory Vet Continuing Education Conference

An emphasis on applying best practices and achieving best outcomes marked Day 2 of the inaugural Regulatory/Official Veterinary Continuing Education conference (#RegVetCE), presented by the NTRA Safety & Integrity Alliance and the Racing Medication & Testing Consortium (RMTC), at Keeneland in Lexington, Ky. The morning was highlighted by a spirited and far-reaching discussion on “The Order of

Contaminated Feed Cause of Canterbury Drug Positives: Thoroughbred Daily News 9/6/16

By: TDN Three Canterbury Park trainers will be held blameless for a total of four positive post-race tests for a banned leanness-promoting livestock feed additive, the track’s board of stewards has ruled. The Aug. 28 decisions to disqualify the positive-testing horses without sanctioning the trainers comes after a Minnesota Racing Commission (MRC) investigation discovered evidence

Drs. Scollay, Arthur, Hovda Voice Support of RCI’s Proposed…: Paulick Report 1/12/15

by Paulick Report Staff Dr. Mary Scollay, Dr. Rick Arthur, and Dr. Lynn Hovda submitted the following letter to the Paulick Report voicing their support of the RCI’s recent decision to establish rules on compounded medications in horse racing: The Association of Racing Commissioners International (RCI) recently announced they have given approval to a Model

RCI Rules to Target Illegal Drug Compounding: The Blood-Horse 1/5/15

By Blood-Horse Staff The Association of Racing Commissioners International said Jan. 5 it is taking steps to ensure regulatory agencies have adequate authority to sanction licensees who violate existing federal restrictions limiting the use of illegally compounded medications. An already approved model rules policy would outlaw the possession or use of a drug, substance, or